8161 — MediNet Income Statement
0.000.00%
Last trade - 00:00
- HK$16.22m
- HK$12.81m
- HK$110.39m
- 41
- 45
- 65
- 49
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 141 | 145 | 129 | 121 | 110 |
Cost of Revenue | |||||
Gross Profit | 64.1 | 71.5 | 70.6 | 65.4 | 56.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 153 | 159 | 125 | 128 | 136 |
Operating Profit | -12.3 | -14.1 | 4.75 | -6.74 | -25.5 |
Net Income Before Taxes | -12.3 | -14.1 | 4.75 | -6.74 | -25.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.4 | -14.9 | 4.75 | -6.38 | -25.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -13.4 | -14.9 | 4.75 | -6.22 | -24.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.4 | -14.9 | 4.75 | -6.22 | -24.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.32 | -0.285 | 0.035 | -0.164 | -0.358 |